Melanoma pathogenesis is initiated by the accumulation of genetic alterations in the neoplastic cells, with mutations in v-Raf murine sarcoma viral oncogene homolog B (BRAF) and neuroblastoma rat sarcoma virus viral oncogene homolog (NRAS) genes being widely accepted as the most common oncogenic drivers [15,39]. This evidence concerns the gene NRAS and melanoma.